Press Release: Pfizer Wins Celebrex Patent Decision in Canadian Court - FierceBiotech

Press Release: Pfizer Wins Celebrex Patent Decision in Canadian Court - FierceBiotech: "NEW YORK--(BUSINESS WIRE)--Pfizer Inc reported today that the Federal Court of Appeal of Canada has reversed a lower court ruling that would have permitted generic manufacturer Novopharm to launch a competitor product to Celebrex. The appellate court issued an order prohibiting regulatory approval of Novopharm's product in Canada until Celebrex's compound patent expires in November 2014."